TSLP and allergic disease: In bronchial epithelial cultures from patients with allergy, asthma, or chronic obstructive pulmonary disease, exposure to viral RNA or synthetic analogue Poly I:C results in significantly increased production of TSLP, as measured by both mRNA expression and protein [41,42], compared to cells cultured from healthy controls.